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Risk factors for thyroid cancer: A prospective cohort study
Stephanie A. Navarro Silvera
1*, Anthony B. Miller
2
and Thomas E. Rohan
1
1Department of Epidemiology and Population Health, Albert Einstein College of Medicine, New York, NY, USA
2Department of Public Health Sciences, University of Toronto, Toronto, Canada
Given the higher incidence rate of thyroid cancer among women
compared to men and evidence that smoking and alcohol con-
sumption may be inversely related to thyroid cancer risk, we
examined thyroid cancer risk in association with menstrual,
reproductive and hormonal factors, and cigarette and alcohol con-
sumption, in a prospective cohort study of 89,835 Canadian
women aged 40–59 at recruitment who were enrolled in the
National Breast Screening Study (NBSS). Linkages to national
cancer and mortality databases yielded data on cancer incidence
and deaths from all causes, respectively, with follow-up ending
between 1998 and 2000. Cox proportional hazards models (using
age as the time scale) were used to estimate hazard ratios and
95% confidence intervals for the association between each of the
potential risk factors and risk of thyroid cancer overall and by the
main histologic subtypes. During a mean of 15.9 years of follow-
up, we observed 169 incident thyroid cancer cases. There was no
evidence of altered overall thyroid cancer risk with any of the
menstrual, reproductive, or hormonal factors. There was evidence
of a decreased risk of papillary thyroid cancer among women with
5 or more live births (vs. nulliparous). Age at which smoking com-
menced, duration of smoking, number of cigarettes smoked per
day, pack-years of smoking and alcohol consumption were not
associated with altered thyroid cancer risk. The present study pro-
vides little support for associations with hormonal factors, smok-
ing, or alcohol consumption, but there is a need for additional
prospective data.
' 2005 Wiley-Liss, Inc.
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Thyroid carcinomas are generally rare, with an annual incidence
rate of approximately 5.7 per 100,000 in the United States.1 Other
than ionizing radiation, the only definitively established risk factor
for this disease,2 little is known about the etiology of thyroid can-
cer. However, given that the incidence of thyroid cancer is consis-
tently higher in women than in men3,4 and the finding that estro-
gen receptors are present in papillary and follicular thyroid carci-
nomas (the 2 major histologic subtypes of thyroid cancer),4 it has
been hypothesized that hormonal factors may be involved in the
etiology of thyroid cancer. Furthermore, there is experimental evi-
dence that elevated thyroid-stimulating hormone (TSH) levels
may play a role in the development of thyroid carcinomas5–9 and
epidemiologic evidence that smoking10–13 and alcohol consump-
tion14 may be inversely associated with TSH production, which
suggests that they might be inversely associated with thyroid
cancer risk.
The epidemiologic literature regarding the risk of thyroid can-
cer in association with menstrual and reproductive factors and use
of exogenous hormones is based primarily on the results of case-
control studies, and findings, with respect to the roles of parity,
age at first birth, age at menarche, oral contraceptive use, use of
hormone replacement therapy and menopausal status, have been
inconsistent.15,16 Similarly, the epidemiologic literature regarding
smoking and alcohol and thyroid cancer risk is also based primar-
ily on case-control studies and the results have largely indicated
inverse associations with ever smoking and any consumption of
beer or wine.17
To date, it appears that there have been only 3 prospective
cohort studies of the associations between reproductive and/or
hormonal factors and thyroid cancer risk,18–20 1 of which20 also
examined the association with cigarette smoking and alcohol con-
sumption. These studies have suggested no association with age at
menarche, duration of oral contraceptive use, postmenopausal
status, ever use of hormone replacement therapy, age at first
birth,18–20 smoking, or alcohol consumption,20 and only 1 out of 3
reported a positive association with parity.19 Two of these pro-
spective studies examined thyroid cancer risk overall and by the
main histologic subtypes of thyroid cancer.18,19 However, one19
focused only on the association between parity and thyroid cancer
risk, and the other18 focused on a limited range of reproductive
and menstrual factors.
Given the current lack of data from prospective studies regard-
ing the etiology of thyroid cancer, we examined the association
between menstrual, reproductive and hormonal factors, smoking
history, alcohol consumption and thyroid cancer risk, overall and
by histologic subtype, in a cohort of Canadian women.
Material and methods
Study population
The design of our study has been described in detail else-
where.21 Briefly, 89,835 women aged 40–59 years were recruited
into the Canadian National Breast Screening Study (NBSS)
between 1980 and 1985 from the general Canadian population.22
Questionnaires
At recruitment into the cohort, participants completed self-
administered questionnaires that sought information on demo-
graphic characteristics, lifestyle factors, menstrual and reproduc-
tive history and use of oral contraceptives and replacement estro-
gens. Specifically, participants were asked questions about their
use of hormone replacement therapy (HRT), use of oral contracep-
tives, age at menarche, number of pregnancies lasting greater than
4 months (parity), age at first live birth and menopausal status.
Information on smoking history was also obtained from partici-
pants by asking them whether or not they had ever smoked; those
who reported ever smoking were then asked to provide informa-
tion on how many cigarettes they smoked per day, how many
years they had smoked and, for former smokers, the year that they
had ceased smoking.
Starting in 1982, a self-administered food frequency question-
naire (FFQ)23 was distributed to all new attendees at all screening
centers and to women returning to the screening centers for rescreen-
ing. The FFQ sought information on usual portion size and fre-
quency of consumption of 86 food items, including the frequency
of consumption of beer, wine and spirits. A comparison between
the self-administered questionnaire and a full interviewer-adminis-
tered questionnaire, which has been subjected to both validity and
reliability testing23 and used in a number of epidemiologic stud-
ies,24 revealed that the 2 methods gave estimates of intake of the
major macronutrients that were moderately to strongly correlated
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with each other.25 A total of 49,613 dietary questionnaires were
returned and available for analysis.
Ascertainment of incident thyroid cancer cases and deaths
Incident cases of thyroid cancer and deaths from all causes were
ascertained respectively by means of computerized record link-
ages to the Canadian Cancer Database and to the National Mortal-
ity Database, both of which are maintained by Statistics Canada.
The linkages to the databases yielded data on cancer incidence
and mortality to 31 December 2000 for women in Ontario, 31
December 1998 for women in Quebec and 31 December 1999 for
women in other provinces. Given the small number of follicular
carcinoma cases in our study population and given that both papil-
lary and follicular carcinomas arise from follicular cells,4 we
examined the role of each of the risk factors of interest among
papillary carcinoma cases alone and combined papillary and fol-
licular carcinoma cases in addition to their association with overall
thyroid cancer risk.
Statistical analysis
Of the 89,835 women for whom data were available, we
excluded women with prevalent thyroid cancer at baseline (n 5
38), leaving 89,797 women available for analyses of hormonal
and reproductive variables, among whom there were 169 incident
cases of thyroid cancer (87 papillary thyroid cancer, 144 combined
papillary and follicular thyroid cancer). In addition, we excluded
women who did not report any information on smoking history
(n 5 1,072), leaving 88,725 women available for analyses of
smoking variables, among whom there were 163 incident cases of
thyroid cancer. Among the 49,613 women who completed an
FFQ, there were 103 incident cases of thyroid cancer (51 papillary
thyroid cancer, 89 combined papillary and follicular thyroid can-
cer). An indicator variable for those missing information on alco-
hol intake was created and included in multivariate analyses of
smoking history and thyroid cancer risk.
Cases contributed person-time to the study from their date of
enrollment until the date of diagnosis of their thyroid cancer, and
noncases contributed person-time from their date of enrollment
until the termination of follow-up or death, whichever was earlier.
Cox proportional hazards models (using age as the time scale)
were used to estimate hazard ratios (HRs) and 95% confidence
intervals (CIs) for the association between each of the potential
risk factors and overall thyroid cancer risk as well as for papillary
thyroid cancer and combined papillary and follicular thyroid can-
cer. All models included age (as the time to event variable) as well
as terms for study center and randomization group (intervention or
control). For analyses of risk in association with cigarette con-
sumption, age at which smoking began was calculated for each
smoker by subtracting the total years of smoking from age at
recruitment. Pack-years of smoking was calculated by multiplying
the total years of smoking by the number of cigarettes smoked per
day divided by 20 (given 20 cigarettes per pack). Multivariate
models for the smoking history analyses included body mass index
[defined as weight (kg)/height (m2); weight and height were mea-
sured at baseline26], highest level of education attained (less than
high school or high school graduate or more) and alcohol con-
sumption (none, 1–3, 3–10,  10, or missing). Multivariate mod-
els for alcohol consumption likewise included body mass index
(BMI), highest level of education obtained and pack-years of
smoking (none, 1–10, 10–19,  20). Multivariate models for hor-
mone and reproductive risk factors included the variables listed in
the footnote of Table II. Menopausal status was determined as fol-
lows: women who reported having regular menstrual periods
within the past 12 months or who had had a hysterectomy without
bilateral oophorectomy and were less than 45 years of age were
classified as premenopausal, while women whose menstrual peri-
ods ceased prior to 12 months before baseline, those who had had
a bilateral oophorectomy and those who had had a hysterectomy
and were over 55 years of age were considered to be postmeno-
pausal. Women who were between 45 and 55 years of age whose
menstrual periods did not cease 12 months before baseline, and
who had not undergone surgical menopause, were classified as
perimenopausal (not included in these analyses due to small num-
ber of thyroid cancer cases in this category; n 5 31). To test for
trends in risk with increasing levels of the exposures of interest,
we either assigned the categorical variables their ordinal number
(parity) or the category median (age at first live birth, duration of
oral contraceptive use, smoking history and alcohol consumption)
and then fitted the assigned value of each risk factor as a continu-
ous variable in the risk models and evaluated the statistical signifi-
cance of the corresponding coefficient using the Wald test.27 Use
of the life test procedure in SAS showed that the proportional haz-
ards assumption was met in this data set (SAS Institute Cary, NC).
All analyses were performed using SAS version 9.
Results
The average duration of follow-up for cohort members was 15.9
years (1,429,037 person-years for the cohort as a whole), during
which 169 incident cases of thyroid cancer were diagnosed, of
which 87 were papillary cancers, 20 were follicular cancers and
37 showed both papillary and follicular histology. Table I shows
the demographic characteristics of the study population by case
status at the end of follow-up. Briefly, cases and controls were
largely similar with respect to age, body mass index, smoking his-
tory, alcohol consumption and each of the hormonal/reproductive
factors (Table I).
Table II shows multivariate adjusted estimates of the risk of
thyroid cancer in association with the menstrual, reproductive and
hormonal variables of interest. Although the adjusted hazard ratios
for each level of parity (compared to nulliparous women) were
below unity with respect to both overall thyroid cancer risk and
risk of the histologic subtypes of interest, most of the point esti-
mates and the associated trends in risk were not statistically signif-
icant. There was likewise no association between parity and thy-
roid cancer among parous women (1–2 live births as referent
group). There was no association between age at first live birth,
age at menarche, menopausal status, use of oral contraceptives, or
use of hormone replacement therapy and risk of thyroid cancer
overall or by histologic subtype.






Mean age (years) 48.0 (5.3) 48.5 (5.6)
Mean BMI (kg/m2) 25.2 (4.3) 25.1 (4.8)
Smoking history (% ever)1 49.7 48.9
Mean age started smoking 22.7 (7.0) 22.7 (7.5)
Mean number of years smoked 17.6 (10.6) 19.0 (10.4)
Mean number of cigarettes
smoked per day
17.8 (11.2) 16.7 (11.2)
Mean number of pack-years 17.9 (15.1) 18.3 (16.7)
Alcohol consumption (% any)2 72.7 76.9
Mean alcohol consumption
(g/day)
10.2 (13.2) 11.1 (14.2)
Mean age at menarche (years) 12.9 (1.5) 12.8 (2.2)






Postmenopausal % 41.3 43.2
HRT use4 (% ever) 47.4 47.0
Oral contraceptive use (% ever) 61.5 58.5
1Results for smoking duration, intensity, pack-years and age started
smoking are among ever smokers only.–2Results for mean alcohol
consumption are among drinkers only.–3Among parous women
only.–4Among postmenopausal women only.
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Table III shows that in multivariate-adjusted models, there was
no association between thyroid cancer risk overall and smoking
history (ever vs. never) or status (never/former/current). In addi-
tion, the number of cigarettes smoked, smoking duration, pack-
years and age at which the study participant began smoking were
not associated with altered thyroid cancer risk. Although there
was a 25% decreased risk of papillary thyroid carcinoma among
current smokers compared to never smokers, this association was
not statistically significant (95% CI5 0.41–1.37).
Consumption of at least 10 grams of alcohol per day was associ-
ated with a 14–20% reduction in thyroid cancer risk after adjustment
for education, BMI and smoking history (pack-years). However, the
reductions in risk were not statistically significant (Table IV).
Discussion
In the prospective study reported here, we found that overall
thyroid cancer risk was not associated with menopausal status,
parity, age at first live birth, age at menarche, oral contraceptive
use, or use of hormone replacement therapy. There was some evi-
dence, however, that relatively high parity may be associated with
decreased risk of papillary thyroid carcinoma.
While we found no association between thyroid cancer risk and
menopausal status in our study population, Negri et al.15 reported
a borderline increased risk among women reporting natural meno-
pause compared to premenopausal women in a pooled analysis of
data from 11 case-control studies. In contrast to the findings
reported by Negri et al.,15 Iribarren et al.20 analyzed data from a
prospective cohort of men and women in the San Francisco Bay
Area (123 incident cases) and reported a 40% reduction in risk
among postmenopausal (nonsurgical menopause) vs. premeno-
pausal women (95% CI5 0.35–1.02).
A number of case-control studies have examined the relation-
ship between parity and thyroid cancer risk.28–39 Although 8 stud-
ies reported odds ratios above unity (comparing parous vs. nulli-
parous),28–30,32,34,36–38 only one of these findings was statistically
significant.38 However, a pooled analysis of 12 case-control stud-
ies (including unpublished data from a case-control study con-
ducted in Nagasaki, Japan) found a borderline increased risk when
comparing parous vs. nulliparous women (OR 5 1.2; 95% CI 5
1.0–1.6).15 In contrast, we found no evidence of an association
between overall thyroid cancer risk and parity. Our findings also
differ from the results of an analysis of complete Norwegian birth
cohorts, which included 1.1 million Norwegian women ascer-
tained through the Central Population Register of Norway (976
incident cases of thyroid cancer), wherein Kravdal et al.19
observed a positive association between parity (defined as the
number of live births) and overall thyroid cancer risk (ptrend 5
0.03; unadjusted analysis). However, our findings for overall thy-
roid cancer risk are similar to those of Akslen et al.,18 who anal-
yzed prospective data for 63,090 Norwegian women (124 incident
cases), and to those of Iribarren et al.,20 both of whom reported no
association between parity and thyroid cancer risk. Unlike the
pooled analysis of case-control data15 and the results reported by
Akslen et al.18 and Kravdal et al.,19 which reported no association
between parity and papillary thyroid cancer, we observed an
inverse association among women with 5 or more live births com-
pared to nulliparous women.
TABLE II – MULTIVARIATE-ADJUSTED HAZARD RATIOS AND 95% CONFIDENCE INTERVALS FOR THE
ASSOCIATION BETWEEN REPRODUCTIVE, MENSTRUAL AND








Nulliparous 1.00 (reference) 1.00 (reference) 1.00 (reference)
Parous 0.75 (0.42–1.33) 0.53 (0.22–1.25) 0.66 (0.35–1.24)
1–2 0.65 (0.35–1.23) 0.45 (0.18–1.16) 0.56 (0.28–1.14)
3–4 0.85 (0.47–1.54) 0.71 (0.30–1.71) 0.76 (0.39–1.46)
51 0.65 (0.32–1.33) 0.23 (0.07–0.80) 0.56 (0.25–1.24)
p2trend 0.63 0.76 0.58
Age (years) at first live birth3
Nulliparous 1.00 (reference) 1.00 (reference) 1.00 (reference)
< 23 0.79 (0.44–1.41) 0.77 (0.34–1.75) 0.79 (0.42–1.50)
23–25 1.13 (0.65–1.97) 1.22 (0.56–2.65) 1.19 (0.65–2.19)
> 25 0.94 (0.55–1.60) 0.97 (0.46–2.06) 0.98 (0.54–1.76)
ptrend 0.41 0.23 0.14
Age (years) at menarche3
< 12 1.00 (reference) 1.00 (reference) 1.00 (reference)
 12 1.03 (0.76–1.41) 0.99 (0.64–1.52) 1.08 (0.77–1.52)
Menopausal status4
Pre 1.00 (reference) 1.00 (reference) 1.00 (reference)
Post 0.80 (0.51–1.26) 0.59 (0.30–1.15) 0.68 (0.41–1.13)
Oral contraceptives3
Never 1.00 (reference) 1.00 (reference) 1.00 (reference)
Ever 1.11 (0.80–1.54) 1.00 (0.64–1.57) 1.09 (0.77–1.55)
1–11 months 1.28 (0.79–2.07) 1.36 (0.73–2.56) 1.40 (0.85–2.32)
12–35 months 1.39 (0.88–2.19) 1.23 (0.66–2.32) 1.41 (0.87–2.29)
> 35 months 0.94 (0.64–1.38) 0.79 (0.46–1.35) 0.85 (0.56–1.30)
ptrend 0.85 0.96 0.60
Hormone replacement therapy35
Never 1.00 (reference) 1.00 (reference) 1.00 (reference)
Ever 1.16 (0.68–1.98) 1.29 (0.56–2.95) 1.45 (0.78–2.69)
1Multivariate adjusted for age (time to event variable), age at first live birth, study center and random-
ization group (intervention vs. control).–2Test for trend among parous women only.–3Multivariate
adjusted for age (time to event variable), parity, study center and randomization group (intervention vs.
control).–4Multivariate adjusted for age (time to event variable), HRT use (ever/never), study center and
randomization group (intervention vs. control).–5Postmenopausal women only.
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Of the 12 published case-control studies that have examined
age at first birth as a risk factor for thyroid cancer,28–32,34–40 10
reported an OR above unity in women with a relatively late age at
first birth (age at first birth modeled continuously, based on a unit
increase of 5 years).28,29,31,32,34–37,39,40 Using pooled data from 12
case-control studies (including unpublished case-control data from
Nagasaki, Japan), Negri et al.15 reported a statistically significant
increased risk of thyroid cancer for women at or above 30 years of
age at first birth compared to women below age 20 at first birth
(OR 5 1.8; 95% CI 5 1.0–1.8). Recently, in a population-based
case-control study in the San Francisco Bay area (608 incident
cases; not included in pooled analysis), Sakoda and Horn-Ross39
reported a 2.8-fold increased risk of thyroid cancer for women
35 years of age vs. those < 20 years of age at first birth among
those of reproductive age (20–44 years old at the time of the
interview). In contrast, no association was found between age at first
birth and risk among women of postreproductive age (45–74 years
old at the time of the interview).39 As did Akslen et al.,18 we found
no association between overall thyroid cancer or papillary thyroid
cancer risk and age at first live birth in our cohort of women who
were between 40 and 59 years of age at baseline.
Our study supports the current literature that age at menarche is
not associated with thyroid cancer risk.15,18,20 Similarly, our find-
ings regarding use of oral contraceptives are consistent with those
of previous studies, which have largely reported no association
with thyroid cancer risk.16,20,39 In contrast to the findings of
Sakoda and Horn-Ross,39 who observed an inverse association
between HRT use and papillary thyroid cancer, we found no asso-
ciation with HRT use in our study population. Our finding is in
keeping with that of the only previous prospective cohort study
that has examined this association for overall thyroid cancer
risk.20
Of the 13 published case-control studies that have examined the
association between cigarette smoking and thyroid cancer
risk,28–35,37,38,41,42 only that of Preston-Martin et al.29 suggested
an increase in risk in association with ever smoking (OR 5 2.0;
95% CI 5 0.5–8.0), although this finding was based on only 6
cases and 3 controls and was not statistically significant. Of the
remaining 12 studies, 11 reported odds ratios below unity, of
which 3 were statistically significant.33,37,38 The pooled analysis
of these studies (including the unpublished data from Nagasaki,
Japan) yielded an OR of 0.7 (95% CI 5 0.6–0.8) when comparing
ever vs. never smokers (among women only).17 There was also a
statistically significant inverse trend between smoking duration
and thyroid cancer risk (p 5 0.03) in this pooled analysis.17 In
contrast, we found no association between smoking duration and
TABLE III – MULTIVARIATE-ADJUSTED HAZARD RATIOS AND 95% CONFIDENCE INTERVALS FOR THE







Never smoked 1.00 (reference) 1.00 (reference) 1.00 (reference)
Ever smoked 1.04 (0.76–1.43) 0.85 (0.55–1.32) 1.07 (0.76–1.51)
Former smoker 1.07 (0.74–1.54) 0.93 (0.56–1.53) 1.14 (0.77–1.69)
Current smoker 1.01 (0.67–1.53) 0.75 (0.41–1.37) 0.97 (0.62–1.54)
Age started smoking (years)
< 20 1.07 (0.70–1.62) 0.86 (0.47–1.55) 1.10 (0.70–1.72)
20–29 0.91 (0.59–1.40) 0.80 (0.45–1.44) 0.96 (0.61–1.51)
 30 1.25 (0.72–2.17) 0.83 (0.35–1.95) 1.20 (0.65–2.23)
ptrend 0.90 0.26 0.24
Number of years smoked
< 10 1.18 (0.70–2.00) 1.04 (0.51–2.14) 1.20 (0.68–2.11)
10–19 0.98 (0.58–1.64) 0.92 (0.46–1.82) 1.01 (0.58–1.75)
 20 1.02 (0.70–1.49) 0.75 (0.43–1.30) 1.05 (0.70–1.58)
ptrend 0.77 0.32 0.30
Number of cigarettes/day
< 10 1.04 (0.63–1.72) 0.66 (0.30–1.46) 1.22 (0.73–2.04)
10–19 0.69 (0.39–1.23) 0.59 (0.26–1.30) 0.58 (0.30–1.13)
 20 1.24 (0.86–1.81) 1.11 (0.67–1.84) 1.27 (0.85–1.91)
ptrend 0.91 0.67 0.65
Pack-years
< 10 1.06 (0.70–1.62) 0.90 (0.50–1.61) 1.16 (0.74–1.80)
10–19 0.79 (0.44–1.42) 0.41 (0.15–1.14) 0.71 (0.36–1.38)
 20 1.17 (0.78–1.75) 1.06 (0.61–1.84) 1.19 (0.77–1.85)
ptrend 0.89 0.43 0.41
Multivariate adjusted for age (time to event variable), education (<high school, high school), body
mass index (<25, 25–29, 30) and alcohol consumption (0 plus 3 levels of intake).
TABLE IV – MULTIVARIATE-ADJUSTED HAZARD RATIOS AND 95% CONFIDENCE INTERVALS FOR THE








None 1.00 (reference) 1.00 (reference) 1.00 (reference)
Any 1.15 (0.73–1.82) 0.99 (0.51–1.90) 0.99 (0.59–1.64)
1–3 1.17 (0.68–2.01) 1.55 (0.75–3.24) 1.50 (0.84–2.68)
3–10 0.67 (0.36–1.22) 0.71 (0.30–1.69) 0.75 (0.39–1.46)
 10 0.80 (0.45–1.42) 0.80 (0.35–1.84) 0.84 (0.44–1.58)
ptrend 0.56 0.49 0.64
Multivariate adjusted for age (time to event variable), education (< high school,  high school), body
mass index (<25, 25–29, 30) and pack-years of smoking (0 plus 3 levels).
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thyroid cancer risk in our study population. Our results support
those of Iribarren et al.,20 who analyzed data from a prospective
cohort study of men and women in the San Francisco Bay Area
(196 incident cases in all, 123 cases in women) who reported no
association between smoking status (never/former/current) and
risk of thyroid cancer.
Of the published case-control studies that have examined alcohol
consumption as a risk factor for thyroid cancer,28,31,32,35,37,38,41,42
5 have reported inverse associations,28,31,35,38,42 of which 2 were
statistically significant,31,38 and the remaining studies reported
odds ratios above unity, although none of them was statistically
significant.32,35,37,41 A pooled analysis of these studies (including
unpublished data from Nagasaki, Japan) reported an OR 5 0.8
(95% CI 5 0.7–0.9) between beer and wine consumption (any vs.
none) and thyroid cancer risk after adjusting for age, gender and
ethnicity.17 However, when the pooled estimate was examined
among women only, there was no association between number of
drinks of wine and beer per week and thyroid cancer risk.17
Although we observed a 20% lower risk of thyroid cancer overall
among women drinking at least 10 grams of alcohol per day com-
pared to nondrinkers, this finding was not statistically significant
and is supported by the similar absence of an association between
alcohol consumption (measured as number of drinks per day) and
thyroid cancer risk reported in the prospective study of Irribarren
et al.20
Our study is the first prospective cohort study to investigate the
roles of smoking and alcohol consumption and of a wide range of
hormonal risk factors with respect to histologic subtypes of thyroid
cancer. The main strength of our investigation is its prospective
study design, which eliminates the possibility of recall bias. As well,
the essentially complete follow-up of the cohort,43,44 based on link-
age to national cancer incidence and mortality databases, reduces
the likelihood that our results reflect bias due to differential follow-
up. Our study is limited, however, by the relatively small number of
cases of thyroid cancer. In addition, our study is limited in that
information on menopausal status was collected only at baseline.
Given that the minimum age at baseline was 40 and that, on aver-
age, there were 16 years of follow-up, it is likely that most of those
who were premenopausal at enrolment would have become postme-
nopausal during the course of follow-up. Similarly, we did not col-
lect additional information on smoking and alcohol intake during
the follow-up period. It is possible that some study participants
altered their smoking and alcohol intake behaviors during follow-
up, thus potentially obscuring the true hazard ratios. Our analyses
were limited somewhat due to the lack of data on radiation expo-
sure. While radiation exposure is a clearly defined risk factor for
thyroid cancer,2 there does not appear to be evidence from the epi-
demiologic literature that radiation is associated with either smoking
or alcohol consumption, or with reproductive factors. Additionally,
data on family history of thyroid cancer were not collected and
therefore could not be controlled for in the analyses. However,
approximately only 3% of thyroid cancer cases have a family his-
tory of the disease and a family history of thyroid cancer appears to
be most strongly associated with medullary carcinomas,4 which
accounted for less than 2% of the cases in our study. Furthermore,
there is no epidemiologic evidence that family history of thyroid
cancer is associated with any of the risk factors under study. There-
fore, radiation and family history of thyroid cancer are unlikely to
have confounded the relationships between smoking history, alcohol
consumption, or reproductive factors and thyroid cancer risk.
Finally, although we adjusted for a number of potentially confound-
ing variables, we cannot exclude the possibility of residual con-
founding by other factors.
In conclusion, the results of our study suggest that parity, age at
first live birth, age at menarche, menopausal status, use of oral
contraceptives, use of hormone replacement therapy, smoking his-
tory and alcohol consumption are not associated with risk of thy-
roid cancer. Despite experimental evidence supporting a detrimen-
tal role of hormonal factors in the etiology of thyroid cancer45–47
and substantial evidence from case-control studies supporting an
inverse association between smoking and alcohol consumption
and thyroid cancer risk,17 the currently available evidence from
prospective cohort studies provides limited support for roles for
these factors, although the number of cases observed in cohorts
has mostly been relatively small. This suggests the need either to
pool the results of existing cohort studies or to conduct additional
larger prospective studies.
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